ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 27 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $185,000 | -44.6% | 21,402 | -8.6% | 0.00% | – |
| Q4 2021 | $334,000 | -18.7% | 23,406 | +25.0% | 0.00% | – |
| Q3 2021 | $411,000 | +79.5% | 18,727 | +9.2% | 0.00% | – |
| Q2 2021 | $229,000 | +1426.7% | 17,149 | +452.7% | 0.00% | – |
| Q4 2019 | $15,000 | -60.5% | 3,103 | -70.5% | 0.00% | – |
| Q1 2019 | $38,000 | -83.3% | 10,527 | -77.5% | 0.00% | – |
| Q3 2018 | $227,000 | -13.0% | 46,695 | +32.6% | 0.00% | – |
| Q2 2018 | $261,000 | +61.1% | 35,205 | +41.3% | 0.00% | – |
| Q1 2018 | $162,000 | -47.9% | 24,914 | -28.0% | 0.00% | – |
| Q4 2017 | $311,000 | +6.5% | 34,608 | +17.6% | 0.00% | – |
| Q3 2017 | $292,000 | – | 29,434 | +588580.0% | 0.00% | – |
| Q2 2017 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 5 | -99.9% | 0.00% | – |
| Q3 2016 | $36,000 | +350.0% | 5,005 | +370.8% | 0.00% | – |
| Q2 2016 | $8,000 | -11.1% | 1,063 | -29.1% | 0.00% | – |
| Q1 2016 | $9,000 | – | 1,500 | +1478.9% | 0.00% | – |
| Q4 2015 | $0 | – | 95 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 366,401 | $2,374,000 | 2.07% |
| Private Portfolio Partners LLC | 67,400 | $436,752 | 0.12% |
| Knoll Capital Management, LLC | 20,000 | $130,000 | 0.08% |
| ETF MANAGERS GROUP, LLC | 94,493 | $612,000 | 0.02% |
| Virtu Financial LLC | 21,526 | $139,000 | 0.01% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 21,904 | $142,000 | 0.01% |
| BOURGEON CAPITAL MANAGEMENT LLC | 5,627 | $36,000 | 0.01% |
| Walleye Capital LLC | 78,418 | $508,000 | 0.01% |
| Jump Financial, LLC | 36,100 | $234,000 | 0.01% |
| Plante Moran Financial Advisors, LLC | 7,911 | $51,000 | 0.01% |